Jakpaisan Estate PCL
SET:JAK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jakpaisan Estate PCL
SET:JAK
|
TH |
|
Novo Nordisk A/S
NYSE:NVO
|
DK |
|
Jinxin Fertility Group Ltd
OTC:JXFGF
|
CN |
|
Carbon Energy Corp
OTC:CRBO
|
US |
|
C
|
Carasso Real Estate Ltd
TASE:CRSR
|
IL |
|
H
|
Halliburton Co
LSE:0R23
|
US |
|
V
|
Vermilion Energy Inc
NYSE:VET
|
CA |
|
Amarc Resources Ltd
XTSX:AHR
|
CA |
|
Riverine China Holdings Ltd
HKEX:1417
|
CN |
|
V
|
Vietnam Pesticide JSC
VN:VPS
|
VN |
|
A
|
avVaa World Health Care Products Inc
OTC:AVVH
|
CA |
|
Itesoft SA
PAR:ITE
|
FR |
|
Floridienne SA
F:OI9
|
BE |
|
A
|
Air France KLM SA
F:AFR
|
FR |
|
F
|
Frontera Group Inc
OTC:FRTG
|
US |
|
C
|
Clean Motion AB
STO:CLEMO
|
SE |
Cash Flow Statement
Cash Flow Statement
Jakpaisan Estate PCL
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
10
|
9
|
(1)
|
3
|
2
|
2
|
32
|
35
|
36
|
40
|
17
|
17
|
29
|
41
|
|
| Depreciation & Amortization |
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
3
|
2
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
(6)
|
(6)
|
(6)
|
(4)
|
(0)
|
4
|
23
|
26
|
28
|
34
|
25
|
25
|
24
|
25
|
|
| Cash Taxes Paid |
2
|
2
|
2
|
1
|
1
|
1
|
3
|
3
|
6
|
6
|
5
|
7
|
7
|
8
|
|
| Cash Interest Paid |
7
|
6
|
7
|
8
|
10
|
11
|
13
|
13
|
13
|
18
|
16
|
16
|
15
|
12
|
|
| Change in Working Capital |
(44)
|
2
|
(68)
|
(139)
|
(177)
|
(193)
|
12
|
25
|
10
|
14
|
5
|
133
|
141
|
108
|
|
| Cash from Operating Activities |
(37)
N/A
|
7
N/A
|
(72)
N/A
|
(138)
-90%
|
(173)
-26%
|
(185)
-7%
|
69
N/A
|
88
+28%
|
76
-14%
|
92
+21%
|
49
-47%
|
185
+278%
|
196
+6%
|
176
-10%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(6)
|
(6)
|
(6)
|
(1)
|
|
| Other Items |
5
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
4
N/A
|
(1)
N/A
|
(1)
+8%
|
(1)
+15%
|
(1)
+21%
|
4
N/A
|
4
+10%
|
4
+2%
|
(1)
N/A
|
(1)
-13%
|
(6)
-401%
|
(6)
-1%
|
(6)
+1%
|
(1)
+77%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
115
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(59)
|
(32)
|
79
|
140
|
189
|
195
|
(52)
|
(81)
|
(49)
|
(65)
|
(16)
|
(156)
|
(163)
|
(107)
|
|
| Cash Paid for Dividends |
0
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(16)
|
(16)
|
(16)
|
(8)
|
(8)
|
(8)
|
|
| Other |
(7)
|
(6)
|
(9)
|
(10)
|
(12)
|
(14)
|
(14)
|
(14)
|
(14)
|
(18)
|
(16)
|
(19)
|
(17)
|
(15)
|
|
| Cash from Financing Activities |
36
N/A
|
(39)
N/A
|
70
N/A
|
130
+85%
|
177
+36%
|
182
+3%
|
(66)
N/A
|
(95)
-44%
|
(79)
+16%
|
(99)
-25%
|
(48)
+51%
|
(183)
-278%
|
(188)
-3%
|
(130)
+31%
|
|
| Change in Cash | |||||||||||||||
| Net Change in Cash |
3
N/A
|
(32)
N/A
|
(3)
+89%
|
(9)
-153%
|
3
N/A
|
1
-83%
|
7
+1 156%
|
(2)
N/A
|
(4)
-93%
|
(9)
-93%
|
(5)
+41%
|
(4)
+27%
|
2
N/A
|
45
+1 921%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(38)
N/A
|
6
N/A
|
(74)
N/A
|
(139)
-88%
|
(174)
-25%
|
(185)
-7%
|
68
N/A
|
87
+29%
|
74
-15%
|
90
+21%
|
43
-52%
|
179
+317%
|
190
+6%
|
174
-8%
|
|